UNIVERSAL STUDIOS, UNIVERSAL STUDIOS SINGAPORE, Universal Globe logo, and all Universal elements and related indicia TM & Â© Universal Studios. All Rights Reserved. Enter the thrilling world of movie magic as you Ride the Moviesâ¢ on roller coasters and other movie-themed attractions.
A replay of the call will be archived on the site for one week following the call. About VIMIZIM â¢. VIMIZIM (elosulfase alfa) is a treatment for patients with Morquio A syndrome, or mucopolysaccharidosis IVA (MPS IVA).VIMIZIM is the first enzyme replacement therapy (ERT) designed to target the underlying cause of Morquio A Syndrome-a deficiency in the enzyme N-acetylgalactosamine-6 sulfatase (GALNS).ntil now, patients with Morquio A syndrome didn't have a drug treatment option. This approval provides the community with a therapy and with hope.. Shipments of VIMIZIM to the distribution channels will commence immediately, and BioMarin will begin promotion of VIMIZIM in the U.S. immediately.
(Also Called 'Remicade for Crohn: Q&A-Medication'). Infliximab, brand name RemicadeÂ®, has been approved by the U.S. Food and Drug Administration for the treatment of Crohn's disease. Infiximab is a biologically engineered antibody that attacks a tumor necrosis factor (TNF) protein that causes intestinal inflammation.ther biologic agents that are now approved for use in Crohnâs disease are: 1  Adalimumab (HumiraÂ®)âa fully human anti-TNF antibody. 2  Certolizumab (CimziaÂ®)âa humanized fragment of an anti-TNF antibody that is pegylated to make it last longer in the body.